Brugada syndrome screening: Difference between revisions

	Brugada syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Brugada syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Examples of Type I Brugada Syndrome
Chest X Ray
Echocardiography or Ultrasound
Electrophysiologic Studies
Genetic Testing
Treatment
Treatment
Drugs to Avoid
Drugs to Preferably Avoid
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Brugada syndrome screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Brugada syndrome screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Brugada syndrome screening
CDC on Brugada syndrome screening
Brugada syndrome screening in the news
Blogs on Brugada syndrome screening
Directions to Hospitals Treating Brugada syndrome
Risk calculators and risk factors for Brugada syndrome screening

VisualWikitext

Revision as of 18:18, 25 November 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Relatives of patients with Brugada syndrome can be screened for the syndrome by obtaining an EKG, although the diagnostic pattern may be concealed. Genetic testing can also be used to support the diagnosis of Brugada syndrome and to detect relatives at risk.^[1] Unfortunately, despite the association of the Brugada syndrome with the SCN5A genotype, there is unfortunately no association between the results of genetic testing and clinical prognosis.

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

[Condition 1]
[Condition 2]
[Condition 3]

References

↑ Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005). "Brugada syndrome: report of the second consensus conference". Heart Rhythm : the Official Journal of the Heart Rhythm Society. 2 (4): 429–40. PMID 15898165. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)

Template:WH Template:WS CME Category::Cardiology

[pmid15898165-1] Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005). "Brugada syndrome: report of the second consensus conference". Heart Rhythm : the Official Journal of the Heart Rhythm Society. 2 (4): 429–40. PMID 15898165. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)

[1]

@@ Line 6: / Line 6: @@
 ==Overview==
 Relatives of patients with Brugada syndrome can be screened for the syndrome by obtaining an [[EKG]], although the diagnostic pattern may be concealed.  Genetic testing can also be used to support the diagnosis of Brugada syndrome and to detect relatives at risk.<ref name="pmid15898165">{{cite journal |author=Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A |title=Brugada syndrome: report of the second consensus conference |journal=[[Heart Rhythm : the Official Journal of the Heart Rhythm Society]] |volume=2 |issue=4 |pages=429–40 |year=2005 |month=April |pmid=15898165 |doi= |url= |issn= |accessdate=2012-10-14}}</ref> Unfortunately, despite the association of the Brugada syndrome with the [[SCN5A]] genotype, there is unfortunately no association between the results of genetic testing and clinical prognosis.
-==Overview==
-There are no established risk factors for [disease name].
+There is insufficient evidence to recommend routine screening for [disease/malignancy].
 OR
-The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
+According to the [guideline name], screening for [disease name] is not recommended.
 OR
-Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
+According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
+==Screening==
+There is insufficient evidence to recommend routine screening for [disease/malignancy].
 OR
-Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
+According to the [guideline name], screening for [disease name] is not recommended.
-==Risk Factors==
-There are no established risk factors for [disease name].
 OR
-The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
+According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-OR
+*[Condition 1]
+*[Condition 2]
+*[Condition 3]
-Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
+**
-===Common Risk Factors===
-*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
-*Common risk factors in the development of [disease name] include:
-**[Risk factor 1]
-**[Risk factor 2]
-**[Risk factor 3]
-===Less Common Risk Factors===
-*Less common risk factors in the development of [disease name] include:
-**[Risk factor 1]
-**[Risk factor 2]
-**[Risk factor 3]
 ==References==
 {{Reflist|2}}

Brugada syndrome screening: Difference between revisions

Revision as of 18:18, 25 November 2019

Overview

Screening

References

Navigation menu